Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease.

MLA

Kao, Chih-Chin, et al. “Investigation of Dual Antiplatelet Therapy after Coronary Stenting in Patients with Chronic Kidney Disease.” PloS One, vol. 16, no. 8, Aug. 2021, p. e0255645. EBSCOhost, https://doi.org/10.1371/journal.pone.0255645.

APA

Kao, C.-C., Wu, M.-S., Chuang, M.-T., Lin, Y.-C., Huang, C.-Y., Chang, W.-C., Chen, C.-W., & Chang, T.-H. (2021). Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease. PloS One, 16(8), e0255645. https://doi.org/10.1371/journal.pone.0255645

Chicago

Kao, Chih-Chin, Mai-Szu Wu, Ming-Tsang Chuang, Yi-Cheng Lin, Chun-Yao Huang, Wei-Chiao Chang, Chih-Wei Chen, and Tzu-Hao Chang. 2021. “Investigation of Dual Antiplatelet Therapy after Coronary Stenting in Patients with Chronic Kidney Disease.” PloS One 16 (8): e0255645. doi:10.1371/journal.pone.0255645.